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Tumours are heterogeneous populations composed of different cells types: stem cells with the capacity for self-renewal and more
differentiated cells lacking such ability. The overall growth behaviour of a developing neoplasm is determined largely by the combined
kinetic interactions of these cells. By tracking the fate of individual cancer cells using agent-based methods in silico, we apply basic rules
for cell proliferation, migration and cell death to show how these kinetic parameters interact to control, and perhaps dictate defining
spatial and temporal tumour growth dynamics in tumour development. When the migration rate is small, a single cancer stem cell can
only generate a small, self-limited clone because of the finite life span of progeny and spatial constraints. By contrast, a high migration
rate can break this equilibrium, seeding new clones at sites outside the expanse of older clones. In this manner, the tumour continually
‘self-metastasises’. Counterintuitively, when the proliferation capacity is low and the rate of cell death is high, tumour growth is
accelerated because of the freeing up of space for self-metastatic expansion. Changes to proliferation and cell death that increase the
rate at which cells migrate benefit tumour growth as a whole. The dominating influence of migration on tumour growth leads to
unexpected dependencies of tumour growth on proliferation capacity and cell death. These dependencies stand to inform standard
therapeutic approaches, which anticipate a positive response to cell killing and mitotic arrest.
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Beyond the genetic alterations known to advance carcinogenesis in
single cells, the overall phenotype of a developing neoplasm is
determined largely at the population level. This is because
evolutionary competition among clones comprising a neoplasm
will assure that only certain of these thrive to define the tumour.
Even after a tumour is established, population-level bottlenecks,
for example, the failure to acquire angiogenic and invasive
competence, may determine whether a fully malignant tumour
ever rises to clinical detection. A tumour can lie dormant below
clinical detection for years (Nielsen et al, 1987; Black and Welch,
1993), limited by competition for nutrients (Folkman, 1971;
Hahnfeldt et al, 1999; Naumov et al, 2006; Abdollahi et al, 2007).
Only tumours that successfully surmount or circumvent all such
population-level constraints will go on to grow. Accordingly,
population-level kinetics are expected to augment cell-level
genetics in driving tumour progression.
One population-level factor limiting tumour progression is the
space to grow (Bru ´ et al, 2003; Pardal et al, 2003; Drasdo and
Ho ¨hme, 2005; Chao et al, 2008). The nature of this limitation has
been debated, given the observation that tumour cells can push
their neighbours under certain circumstances. However, as studied
by Bru ´ et al (2003) and confirmed by Drasdo and Ho ¨hme (2005),
this ability is confined to a thin layer of cells near the surface of
tumours and even to a thin ring of cells at the outer edge of well-
nourished confluent tumour cell populations in vitro. Cells deeper
in the tumours are limited by the surrounding cell mass. The
transition of exponential to linear growth in tumour diameter
(corresponding to dV/dt¼kV
2/3), noted when the tumour
spheroids reach about 200mm in diameter (Drasdo and Ho ¨hme,
2005) suggests that the thickness of this zone for solid tumours is
just 100mm or so.
A second key factor proving to be important is proliferation
capacity. According to the cancer stem cell hypothesis that has
now garnered substantial support (Al-Hajj et al, 2003; Singh et al,
2003; Boman and Huang, 2008; Kakarala and Wicha, 2008),
tumour cells do not all divide indefinitely, as tacitly assumed
in the classic carcinogenesis paradigm (Hanahan and Weinberg,
2000). Instead, only a small fraction of cells have the capacity for
limitless division and self-renewal (the so-called ‘cancer stem
cells’). The rest are able to divide only a certain number of
times before they deplete their generational capacity. Supporting
the theory, small cancer stem cell populations are strongly
implicated in leukaemia (Furth and Kahn, 1937; Kavalerchik
et al, 2008) and tumour-initiating side populations have also
recently been identified in solid tumours of the breast, colon and
prostate, for example (Al-Hajj et al, 2003; Boman and Huang, 2008;
Kakarala and Wicha, 2008; Maitland and Collins, 2008; Price et al,
2008).
Taking these basic population-level features into account, we
designed an agent-based computer model of cancer cell dynamics
operative throughout tumour development (see Anderson et al
(2007) and Deutsch and Dormann, (2005) for similar approaches).
Tracking three cell-level kinetics – cell death, proliferation capacity
and migration rate – in a simulated cancer cell population
composed of cancer stem and non-stem cells, we show how they
interact to produce emergent population-level effects. Owing to the
strong limitation on the ability of tumour cells to push on other
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stumour cells, for example, clustering of progeny around the
tumour is seen to cause cell crowding and consequent self-
inhibition of the tumour as a whole if most cells have a limited
generational life span. If instead the tumour cells tend to separate,
distinct tumour clusters arise and grow to a larger total size
because of a decreased self-inhibition resulting from a lower
average cell density. A larger tumour is the result.
In this way, metastasis and tumour growth are interrelated. It is
understood that metastases arise from cancer stem cells that
escape the primary cell cluster to seed independent clusters
elsewhere. It has been proposed that some of these cells might
either expand into, or circulate and reappear at the edge of the
primary site, fuelling local growth by ‘self-metastasis’ (Norton,
2005; Norton and Massague, 2006). We show how the combined
actions of migration, limited proliferation and cell death combine
counterintuitively to advance tumour development, and how cell
migration, in particular, might drive self-metastatic growth
through the seeding of new tumour clones directly in the tumour
vicinity.
Interestingly, these mechanisms reproduce population-level
behaviours often attributed to higher-order biological processes.
As cases in point, the impact of cell crowding and the importance
of migration have earlier been analysed in a model of vascular
tumour growth (Betteridge et al, 2006). The authors reported that
with increasing tumour carrying capacity because of increased
vasculature, significant cell movement increases the rate of tumour
growth and invasion. In another study, an agent-based approach
was used to study emerging patterns in tumour systems (Mansury
et al, 2002). In this model, heterogeneous nutrient concentrations
and directed cell migration towards nutrient attractors were
determined to be necessary for cluster formation. With our
simpler model, however, we could reproduce this finding without a
structured environment. This leads us to propose that some
considerations of higher-order biological mechanisms in tumour
modelling, while providing new insights into tumour growth
control, may be ascribing higher-order mechanisms to tumour
growth characteristics that can be explained by more basic cell-
level kinetics.
METHODS
An agent-based model is employed that treats cells as ‘agents’ that
follow a specific set of rules influenced by the local environment.
The evolution of the population, starting from a single cancer stem
cell, is tracked by following cell actions in a computational
domain. The computational domain consists of a 350 350 array
of square lattice points, each measuring 10 10mm. Each lattice
point can accommodate at most one cell at any time. Each cell can
proliferate after 1 day, provided the daughter cell can enter an
empty adjacent lattice point. An adjacent lattice point is here
defined as one of the eight lattice points surrounding a given lattice
point (Figure 1A). We start the simulations with a single cancer
stem cell with unlimited replicative potential r¼N placed at the
centre of the domain (the lattice point 175 rows down, 175
columns across). To accommodate the known limitation on cancer
cell growth imposed by space constraints (Bru ´ et al, 2003; Drasdo
and Ho ¨hme, 2005; Galle et al, 2009), if all eight adjacent lattice
points are occupied, a cell is considered inhibited and sent into
quiescence until neighbouring space becomes available. Similar
computational assumptions were made in a recent in silico model
of opportunistic preneoplastic lesion growth driven by the death of
adjacent normal stem cells (Chao et al, 2008). How these
assumptions are consistent with a tumour expanding into normal
tissue has been argued based on a principle of compactness
(Norton, 2005). Considering normal breast tissue to be only 75%
compact compared with 100% for tumours (logical estimates based
on mammography), a tumour would invade the less dense normal
tissue, but not vice versa. At the same time, the tumour would be
limited with respect to invasion within its own 100% compact mass
because of the strongly limited ability of tumour cells to push
themselves, as discussed earlier.
In light of evidence for a small cancer stem cell fraction in the
tumour mass, we further assume that stem cells either divide
symmetrically to produce another stem cell with a small
probability, ps, or divide asymmetrically with probability, 1–ps,
to produce a stem cell and a non-stem progeny cell with
proliferation capacity r¼rmax. A default value, ps¼1%, was
selected as representative, reflecting (1) the order of magnitude of
stem cell frequency observed in solid tumours (Visvader and
Lindeman, 2008), and, as we later discuss, (2) the surprising
insensitivity of the basic tumour growth characteristics for ps
values ranging from 1 to 50% and beyond. If non-stem cells divide,
their proliferation capacity r decreases by 1, and the daughter cells
inherit the new r (Figure 1B). Eventually, these cells exhaust their
proliferative capacity and cease dividing. The disposition of such
cells has been the subject of a number of papers. In a study
comparing breast tumour stem and non-stem cells, Li et al (2007)
measured telomerase activity and found that cancer stem cells
show a higher level of telomerase enzyme activity than non-stem
cancer cells. Zhang et al (1999) showed that telomerase inhibition
in tumour cells triggers apoptotic cell death. Taken together, the
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Figure 1 Cell migration and proliferation. Tumour cells come to occupy adjacent lattice points by two means, migration and proliferation. (A) A cell can
randomly migrate to one of the eight adjacent lattice points, if one is available, vacating the original lattice point, or it can proliferate, with a daughter
randomly occupying an adjacent lattice point, if one is available (green cell, left panel). If all the eight lattice points contain a cell, a cell attempting to migrate
will do nothing, and a cell attempting to divide will become quiescent instead (blue cell, right panel). (B) Proliferation of a cell is ultimately limited by its
proliferation capacity. Cancer stem cells (CSCs) have unlimited replicative potential and self-renewing ability. With probability, ps, a new CSC is produced,
and with probability, 1-ps, a non-stem progeny cancer cell is produced that, with each division, loses proliferation capacity until proliferation is exhausted and
the cell dies.
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sresults suggest that non-stem tumour cells mostly undergo cell
death after exhaustion of generational capacity. Accordingly, we
remove cells from the domain when their proliferation capacity is
exhausted, that is, r¼0.
With equal likelihoods, cells can migrate randomly into one of
the adjacent available lattice points (a typical rate being
0.00635mmh
 1 or about m¼15 cell widths per day (Maini et al,
2004) or remain stationary. At each time of potential proliferation,
we further assume that cancer cell death occurs spontaneously and
randomly among non-stem cells with probability a. Different
sources of spontaneous cancer cell death exist; for instance,
spontaneous cell apoptosis (Meggiato et al, 2000) has been
estimated to be in the order of 1–25% in breast cancer (Ehemann
et al, 2003). A schematic of the cell life cycle scheme in our
computational model is shown in Figure 2. We run each stochastic
simulation for t¼20 365 days, that is, 20 years, unless the
domain becomes confluent sooner.
RESULTS
We use the agent-based model to simulate tumour development
dynamics with various cellular migration potentials (i.e., m¼0, 5
and 15 cell widths per day), non-stem cancer cell proliferation
capacities (i.e., rmax¼10, 15, 20 divisions), and spontaneous cell
death rates (a¼0 and 5% per day). When a single cancer stem cell
is placed in the centre of the domain and cellular migration and
spontaneous cell death are disabled (m¼0 and a¼0%, respec-
tively), proliferation and cell death after proliferation capacity is
exhausted are the defining tumour dynamics. The first daughter
cell is produced after t¼1 day. Both cells, without migration,
occupy adjacent spaces, and their next generation progeny are
placed next to their respective parents. Therefore, on a two-
dimensional lattice, the cancer stem cell can initially produce at
most eight daughter cells (if none of the first daughter’s progeny
randomly places a daughter cell next to the stem cell), and in the
least favourable case only three daughter cells (if all the first
daughter’s progeny are randomly positioned next to the stem cell),
before it becomes space-inhibited and thus quiescent. The cancer
stem cell divides symmetrically with probability, ps¼0.01, to
generate a sister cancer stem cell. Even if a second cancer stem cell
arises before all neighbouring lattice points are occupied by
progeny to the first stem cell, that second stem cell would also
produce daughter cells and, thus, likely be forced to remain resting
until exposed to space again. In this scenario, it is clear that the
tumour growth dynamics are not based on cancer stem cells, but
on their progeny. The cells proliferate if space is available or
become quiescent, otherwise. The tumours grow initially exponen-
tially, but only up to a certain size, depending on the life span of
the non-stem progeny. Tumour size then remains pseudostable
over the long term, subject to short-term oscillations due to cancer
cells dying and previously quiescent cells becoming active again
(case for rmax¼10, m¼0 and a¼0% shown in Figure 3).
Depending on rmax, it may take a long time until the stem cells
become exposed to space again and potentially divide symme-
trically to produce another cancer stem cell. Tumours with non-
stem cell proliferation capacities, rmax¼15 and rmax¼20, and
disabled migration and spontaneous cell death remain non-
growing for the simulated t¼20 years with average sizes of
213±36 cells and 430±31 cells at the end of the simulation,
respectively (n¼40 simulations) (Figure 4A–C). With a cancer
cell migration of five cell widths per day (m¼5), the cluster can
expand as more cells have space available to proliferate, resulting
in tumours with average sizes of 1641±683 cells (for rmax¼15)
and 1916±351 cells (for rmax¼20). However, even in this case
there is insufficient opportunity for symmetric stem cell divisions
to take place, and no appreciable tumour growth takes place over
the 20 years simulated (Figure 4c). If the tumour cells have some
migratory ability (m¼5) and also have progeny with a low
proliferation capacity (rmax¼10), frequent symmetric stem cell
divisions can be observed resulting in a stem cell pool of 239 cells
and an average tumour size of 87506 cells after about 16 simulated
years. A further increase in migration (m¼15) for rmax¼10 results
in a similar tumour size of 88237 cells (131 cancer stem cells) in as
short as 4 years. On the other hand, tumours with a cellular
migration rate, m¼15, and progeny proliferation capacities,
rmax¼15 and rmax¼20, will only feature on average 4.7 and 1.2
stem cells, and produce final tumour sizes of 10051 and 4393 cells
after t¼20 years, respectively. Interestingly, the combination of a
high migration rate (m¼15) and a low progeny proliferation
capacity leads to a qualitative change in the behaviour of the
All cells
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Figure 2 Cell life cycle scheme. At each time step, the cell age increases.
The cell can migrate, and if maturation age is reached the cell can
proliferate, if space is available, or enter quiescence otherwise. If
proliferation capacity is exhausted the cell dies; otherwise, it produces a
daughter cell.
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Figure 3 Tumour population dynamics for t¼0–90 months with low
progeny proliferation capacity (r¼10), and disabled migration and
spontaneous cell death (i.e., a¼m¼0). The tumour size oscillates because
of dying cells at the outer rim, which get replaced by cells from the tumour
core that were previously quiescent. The initiating single cancer stem cell is
not liberated sufficiently to divide symmetrically, resulting in a pseudo-
steady-state tumour size at around 110 cells.
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Figure 4 Tumour growth dynamics over time for representative parameters. For progeny proliferation capacities, r¼(10,15,20), migration rates,
m¼(0,5,15) and spontaneous cell death rates, a¼(0%, 5%), per day, tumour growths are simulated. (A) Representative simulation results after t¼38
months. Without cell death and migration (a¼m¼0), no malignant tumour can form. With increasing migration rate, the tumours grow bigger, but for
tumours with low progeny proliferation capacity (rmax¼10) symmetric stem cell divisions occur frequently, allowing for tumour growth expansion.
Increasing the spontaneous death rate to a¼5% liberates the stem cells to develop multiple clusters of tumour cells, if the migration rate is sufficiently high.
S: number of cancer stem cells; n: number of cancer cells. (B) Average cell counts. Average cell counts are shown at t¼38 months for different migration
rates and proliferation capacities for 40 simulations each, without (a¼0) and with (a¼5) spontaneous cell death. (C) Average tumour growth curves for all
parameters for t¼240 months (i.e., 20 years). The vertical dotted lines show the tumour cell count at t¼38 months.
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spopulation. These migrations into lower-density space favour the
local expansion of stem and non-stem cells alike, but because stem
cells may now engage in more frequent symmetric divisions,
further cycles of stem cell seeding and colony expansions are
enabled. In aggregate, the growing tumour mass consists of
conglomerates of independent cell clusters developing in the
vicinity of each other – the product of a continual ‘self-metastasis’
process that has recently been proposed to drive tumour growth
(Norton, 2005; Norton and Massague, 2006).
Unexpectedly, our studies show that tumour progression is
promoted when the non-stem progeny are short-lived. To test the
limits of this counterintuitive effect, we introduced spontaneous
cell death at a¼5% per day to see how the system would respond
to the further availability of space at the expense of a portion of the
non-stem progeny. Incredibly, tumours with short-lived progeny
(rmax¼10), migration rate, m¼15, and spontaneous cell death,
a¼5%, expand dramatically and populate almost the entire
domain (100000 cells) with 272 stem cells on average in just over
3 years, that is, t¼38 months (Figure 4). At this time, tumours
with higher proliferation capacities (rmax¼15 and rmax¼20)
attain sizes of only 15701 cells (with 10 stem cells), and 6542 cells
(with 3 stem cells), respectively. Without migration, symmetric
stem cell division can be seen, but the tumour cannot expand. The
results collectively show that migratory ability dominates the
kinetics. If the migration rate is insufficient, no values for
proliferation and cell death can overcome tumour inhibition. By
contrast, if migration is high, tumour size advances for a broad
range of proliferation capacities and cell death rates, with both
exerting counterintuitive long-term effects on the migration-
enabled growth. Substantial paradoxical increases in ultimate
tumour size attained are observed as a increases from 0 to 5%
(when rmax¼10, 15 or 20), and as rmax decreases from 20 to 10
(when a¼0 or 5%).
The phenomenon of self-metastasis is largely determined by the
migration rate, but is assisted by a low proliferation capacity.
Simulations show that cells in the tumour core are predominantly
quiescent, and cell proliferation occurs almost exclusively on the
tumour boundary. Figure 5A shows the spatiotemporal evolution
of a tumour exhibiting the hallmark of self-metastasis – cluster
formation at the tumour periphery fuelled by stem cells that have
migrated away from the main mass. Potent cells along with the
cancer stem cells are located in the core of individual clusters, and
the outer rim consists of cells with low remaining proliferative
capacity, r. Visualisation of the proliferative state shows that
proliferation occurs predominantly on the outer rim of the
tumour, and the cells with high proliferative capacity reside in
the quiescent core. In a study of the proliferation distribution
of HCT116 cells in culture, Galle et al (2009) showed that
proliferation indeed occurs mainly on the the tumour boundary. In
line with our simulations, proliferation frequency decreases
towards the tumour core, where proliferation is almost completely
absent. Similar results were reported by Bru ´ et al (2003), who have
attributed intra-tumoural quiescence to the pressure exerted on
the cells through lack of space. Cells proliferate if they have enough
space, but become inhibited with increasing cell density
(Figure 5B). An exponential decrease in mitotic cell distribution
from the tumour boundary to the core is observed, both in vitro
using BrdU staining in a Hela cell line and in vivo using a Ki-67
marker in colon adenocarcinoma. Remarkably, in the in vivo
study, the decrease of proliferation was not because of hypoxia as
blood vessels were present.
We further find that all the common features of cell growth,
including initial formation of gaps in tumour clones, the filling of
those gaps and growth by self-seeding of clones (Figure 6) are all
readily explained by the same basic kinetics as can account for
migration- and space-limited growth. Moreover, the importance of
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Figure 5 (A) Spatiotemporal evolution of the self-metastatic tumour population at different time points. Shown is the proliferative capacity and the
proliferative state distribution. Proliferation mainly occurs on the tumour boundary, and cells with high proliferative capacity are located in the quiescent core.
(B) Cell proliferation analysis with BrdU staining in a HCT116 cell population growing in culture at 7 and 13 days and radial distribution of BrdU positive cell
frequency (reproduced by kind permission of Springer, from Galle et al, 2009).
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smigration in these several roles is seen not to be a two-dimensional
artifact, but persists and is even facilitated in three dimensions
owing to the increased opportunity for a given cell to move to an
adjacent lattice point (Figure 7). In this process, it is noted that
both stem and non-stem cells initiate new clones, although it is
only the stem-cell-initiated clones that persist.
DISCUSSION
In this study, we developed an individual cell agent-based model of
early tumour growth on the basis of the dynamics of cancer stem
cells and their progeny tumour cells with limited proliferation
capacity. In line with earlier studies, our model shows that
increased migration drives the tumour progression (Betteridge
et al, 2006), but in contrast to another model attributing similar
results to patterned environments (Mansury et al, 2002), our study
shows that complex dynamics and spatial agglomeration of
tumour clusters can occur even when the environment is
homogeneous and migration undirected. Although clusters can
arise from gradated environments, this dependence should not be
taken as absolute. Rather, we show that tumour growth coincides
with cluster formation, and that such clusters can form in the
absence of gradients. Although these results should not be taken to
mean that effects due to larger-scale tissue-level dynamics, for
example, angiogenesis and immunity, are just elaborations of
effects already accounted for by cell-level kinetics, they do alert us
to the possibility of effect overlaps that may confound causal
inference.
Single-cell-based experimental models and their computational
counterparts have proven to be a powerful tool to mimic, compare
and explain cell behaviour in vitro, especially in monolayer
cultures and three-dimensional spheroids (Drasdo and Ho ¨hme,
2005). As confirmed in silico, tumour growth in vitro is well
described by an initially exponential growth followed by a sub-
exponential phase, because of inhibition of proliferation in the
tumour interior. Proliferation occurs predominantly on the outer
rim, with cells in the interior being quiescent because of space
inhibition or becoming necrotic because of oxygen or glucose
deprivation. Experiments have also shown proliferation age to be
higher near the outer rim in the sub-exponential populations.
Basanta et al (2008) have described the interplay of proliferative
and motile phenotypes in a developing tumour using game theory,
applying fitness cost tradeoffs between the two phenotypes. Motile
cells migrate away from cell clusters so that when they become
proliferative, they promote tumour expansion. With increasing
costs of motility, however, the fraction of proliferative cells
increases and interestingly reduces tumour invasion. Although
their approach was different, their results and ours both suggest
that cell movement may be a critical determinant of tumour
growth. In other computer models, tumour invasion was
characterised by the transformation of a spherical tumour into
fingering morphologies (Anderson, 2005). Invasive morphologies
emerge upon harsh microenvironmental conditions, and the
dynamical changes are driven by extreme changes in nutrient
supply during tumour development (Anderson et al, 2009). They
found that in a homogeneous environment without haptotactic
and chemotactic gradients to direct cell migration, the tumour
morphology is persistently radially symmetric. Our results go on to
show that fingering morphologies may also happen in homo-
geneous environments. One rationalisation for this vis a vis those
studies may be that our assumption of a small stem cell fraction
may effectively allow for a source of heterogeneity within the
population that substitutes for the lack of milieu heterogeneity
considered by Anderson et al to be necessary for expression of this
phenotype.
Our study has focused on three critical intrinsic mechanisms
that determine individual cell behaviour – proliferation, migration
A
B
Figure 6 (A) All the common features of cell growth, including initial formation of gaps in tumour clones (left) and growth by self-seeding of clones
(right), can readily be explained by basic cell kinetics. The arrows indicate locations of cancer stem cells in the simulation with parameters, r¼10, a¼5%
and ps¼1%. (B) Shown for comparison are tumourigenically transformed murine lung fibroblasts displaying migration-dependent clusterings arising from a
single-plated cell per well.
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sand cell death. Computer simulations of the model indicate that
only certain parameter regions of the three-dimensional parameter
space (proliferation capacity, migration rate and cell death rate)
are consistent with malignant tumour growth, and that the
dependence can be complicated. Non-monotonic dependencies
were noted for both proliferation capacity and cell death rates for a
given migration rate. In our model, each stem cell is only capable
of producing a tumour cluster of a limited size, unless progeny
proliferation capacity, spontaneous cell death and migration rate
are such as to provide space for the reproduction of stem cells and
growth of their non-stem-cell progeny. Increasing the cell death
rate or decreasing the proliferation capacity within certain ranges
counterintuitively helps to liberate stem cells that need space to
proliferate. In addition, the main consequence of increasing the
stem cell renewal probability, ps, from 1% assumed throughout is
only a slight increase in the degree of branching of the tumour
(Figure 8), up to percentages as high as 50%. Still higher
percentages lead to progressively decreasing branching, until at
100%, a smooth circular tumour results (Anderson, 2005; Drasdo
and Ho ¨hme, 2005). It is concluded that, although the branching
morphology relies on the presence of stem cells, the phenotype will
disappear if we adopt the common presumption that all cancer
cells are cancer stem cells.
One consistent feature of malignant tumour growth is the ability
of cancer stem cells to migrate into less dense space to form
separate tumour clusters. The aggregate growth of all tumour
clusters results in population dynamics that are widely observed –
initial exponential growth, followed by a linear growth and a final
plateau phase. The observed tumour population dynamics support
a recent hypothesis of Norton and coworkers (Norton, 2005;
Norton and Massague, 2006) that a tumour grows by a process of
self-metastasis – the shedding of stem cells into the tumour
periphery that expand and merge to advance the tumour
boundary. Cell migration is necessary for the self-seeding process,
and without migration, the tumour will be forced to remain
dormant (Figure 4).
More broadly, the dependence of stem cell kinetics on cluster
formation, made possible by focal separation, may inform our
understanding of how stem cell prevalence and distribution relate
to tumour growth overall. For cancer, gaining an improved
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Figure 7 Three-dimensional simulations elucidating the pivotal role of migration in tumour growth and progression. (A) Without migration (m¼0, top
row), no cells can be shed from the tumour to form foci of micrometastases and the tumour remains dormant. Cancer cell migration (m¼15, bottom row)
is necessary to exhibit tumour growth and progression over time (t¼70, 180, 525 days, left to right) through the formation of self-metastases. (B) High-
resolution visualisation of a representative three-dimensional tumour cluster after the cancer stem cell (CSC) (yellow) has divided (arrows). Both stem cells
are in the core of the tumour cluster with a radial proliferation capacity gradient.
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sunderstanding of how tumours can be driven by independently
growing clusters governed by the rules of proliferation, cell
death and migration may offer new insights into potential
treatment strategies. As observed by Norton, current anti-
proliferative cancer drugs have proven to shrink tumours, but fail
to provide actual cures (Norton and Massague, 2006). Our
model suggests that discouraging migration might provide an
alternative means of cancer suppression. Importantly, the results
suggest that anti-mitotic treatments alone, despite killing cancer
cells, may actually promote tumour progression if eradication of
cancer stem cells cannot be achieved (Michor et al, 2005; Dingli
and Michor, 2006; Yang and Wechsler-Reya, 2007). Alternatively,
in line with observations of Basanta et al (2008), discouraging
migration may be an important new means of cancer suppression.
How this would be facilitated using agents that rely on possibly
counterproductive targeting is not straightforward. On the other
hand, by iteratively refining agent-based models that track
population-level responses to multimodality approaches, strategies
that provide a more favourable long-term treatment response can
be expected.
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Figure 8 Symmetric division rate and tumour morphology in simulations
of tumour growth up to 100000 cells. Symmetric division rates of ps¼25%
and ps¼50% result in self-metastatic growth comparable with ps¼1%
(Figures 4–7). The stem cell pool in each tumour cluster increases with
increasing ps and cancer stem cells are enriched in the tumour core. A
tumour composed of only stem cells, that is, ps¼100%, features a radially
symmetric morphology. Parameters are rmax¼15, m¼15 and a¼1.
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